Do All Telehealth Providers Offer the Same GLP-1 Medications?
Author
glp winnerDate Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
Direct answer
No. Telehealth providers do not all offer the same GLP-1 medications. Availability depends on FDA approval status, the medical condition being treated, state regulations, pharmacy partnerships, and each provider’s clinical protocols.
That difference matters more than most people expect.
Why this question comes up so often
From the outside, many telehealth platforms look similar. They use overlapping language, reference the same medication class, and often promise similar outcomes.
But telehealth care is not standardized.
Behind the scenes, each provider decides:
- which GLP-1 medications they support
- which conditions they treat
- which pharmacies they work with
- and what criteria must be met before prescribing
- For those that offer compounded medications, they also decide what additives they will compound with
That’s why availability varies and which provider you go with is a big decision.
What counts as a GLP-1 medication?
GLP-1 receptor agonists are prescription medications that act on hormone pathways involved in blood sugar regulation and appetite.
FDA-approved GLP-1 or GLP-1–based medications include:
- Ozempic (FDA-approved for type 2 diabetes)
- Wegovy (FDA-approved for chronic weight management and cardiovascular risk reduction)
- Mounjaro (FDA-approved for type 2 diabetes)
- Zepbound (FDA-approved for chronic weight management)
Each medication has specific FDA-approved indications, and telehealth providers typically design their offerings around those labels.
Why telehealth providers don’t all offer the same GLP-1s
This usually comes down to a combination of factors.
FDA approval and clinical scope
Some providers focus only on weight-management indications. Others focus on diabetes care. Some do both.
If a provider does not support a specific indication, they may not offer the corresponding medication at all.
Pharmacy partnerships
Telehealth providers rely on partner pharmacies for fulfillment. If a pharmacy cannot dispense or ship a specific medication in certain states, that medication may not be offered through that platform.
State-level prescribing rules
Telehealth prescribing is regulated state by state. Providers may limit their medication menu to reduce regulatory complexity across jurisdictions.
Supply constraints
When manufacturers report shortages or constrained supply, providers may pause new prescriptions or narrow availability temporarily.
What about compounded GLP-1 medications?
This is an important and often confusing part of the landscape.
Some telehealth providers work with licensed compounding pharmacies to offer compounded GLP-1 formulations when clinically appropriate and permitted by law.
A few key things to understand:
- Compounded GLP-1 medications are not FDA-approved though do come from an FDA-inspected pharmacy.
- They are custom-prepared by a compounding pharmacy based on a prescriber’s order.
- Formulations can vary between pharmacies.
Why compounded options differ between providers
Compounding pharmacies may:
- use different base formulations
- compound under different protocols
- include different inactive ingredients or additives (such as vitamins or amino acids)
Because of this variability:
- two compounded GLP-1 prescriptions may not be identical
- availability depends on the specific pharmacy partnership
- prescribers decide whether a compounded option is appropriate for an individual patient by partnering every patient with a clinician
Pharmacies themselves may be licensed and inspected at the facility level, but the compounded medications do not go through FDA drug approval, and their safety and effectiveness have not been established in the same way as FDA-approved medications.
That’s why compounded offerings vary widely across telehealth providers.
What this means if you’re choosing a telehealth provider
It’s normal for providers to differ. What matters is clarity.
You should be able to get answers to these questions easily with any provider website:
- Which GLP-1 medications do you prescribe?
- Is the medication FDA-approved for the condition you treat?
- Are you licensed to offer medications in the state I live in?
- Do you work with a compounding pharmacy, and if so, which one?
- How do you make sure the medication is shipped safely?
If you’re not able to find an answer to the above questions, you should be able to reach out to the provider support inbox and the team will help you.
Bottom line
GLP-1 is a medication class, not a single product, and each provider and medication is different.
Telehealth providers vary in what they offer because they operate under different clinical models, regulatory environments, and pharmacy partnerships. That variation isn’t automatically good or bad, but understanding it upfront helps avoid surprises and frustration.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Keep Reading
Learn common GLP-1 terms like semaglutide, tirzepatide, FDA-approved, off-label, and compounded in plain English with trusted sources.
How clinicians determine GLP-1 eligibility for weight management or type 2 diabetes, including BMI criteria, medical review, and FDA approval status.
Starting GLP-1s in 2026? A practical, low-pressure guide to building sustainable habits without January burnout.
Do GLP-1 medications qualify for HSA or FSA payment? Learn when prescriptions are eligible, what documentation is required, and how plans differ.
Curated by
